Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROAD: Ramosetron vs Ondansetron for CINV
NCT01536691Phase 3Unknown
- Sponsor
- Hallym University Medical Center
- Start
- Jun 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Hallym University Medical Center. Status: unknown.
02
Drugs
ramosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01536691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536691.